Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Alkynyl monosaccharide analogues as a tool for evaluating Golgi glycosylation efficiency: application to Congenital Disorders of Glycosylation (CDG)

Abstract : The visualization of Golgi glycosylation defects in patients' cells with Congenital Disorders of Glycosylation (CDG) is challenging and necessitates the use of cumbersome glycan analysis methods that are barely adapted to clinical research. We show here that metabolic labelling of patient cells with alkyne-tagged sialic-acid (SiaNAl) enables an easy and reliable readout assay for the detection of CDG occurrence. It also provides valuable clues regarding the pathological processes by assessing the distribution of sialic acid analogues within the cells.
Liste complète des métadonnées

https://hal.univ-lille.fr/hal-03157338
Contributeur : Lilloa Université de Lille Connectez-vous pour contacter le contributeur
Soumis le : mercredi 3 mars 2021 - 10:00:59
Dernière modification le : vendredi 1 octobre 2021 - 09:54:12

Lien texte intégral

Identifiants

Collections

Citation

Jorick Vanbeselaere, Dorothee Vicogne, Gert Matthijs, Christophe Biot, Francois Foulquier, et al.. Alkynyl monosaccharide analogues as a tool for evaluating Golgi glycosylation efficiency: application to Congenital Disorders of Glycosylation (CDG). Chemical Communications, Royal Society of Chemistry, 2013, Chemical Communications (Cambridge, England), 49 (96), pp.11293-11295. ⟨10.1039/c3cc45914d⟩. ⟨hal-03157338⟩

Partager

Métriques

Consultations de la notice

20